VALN•benzinga•
Pharming For 2025 Expects Product Sales Of €170M–180M And Total Revenues Of €180M–190M; Sees R&D Investments Of €90M–100M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga